Empaglifozin belongs to a class of medication called SGLT-2 inhibitors. It works by preventing the reabsorption of sugar and facilitating its excretion in urine to control blood sugar levels. It is indicated for the treatment of type 2 diabetes mellitus and prevention of cardiovascular disease in diabetic patients.
Empagliflozin is taken orally as tablets. The usual initial dose is 10 mg once daily in the morning. You may increase the dose to 25 mg once daily after 4-12 weeks if needed to achieve glycemic goals.
Common side effects of Empagliflozin include increased urination, increased thirst, urinary tract infection, or vaginal yeast infection.
Common dosing schedule:
Empagliflozin should be administered in the morning, with or without food.
This schedule is for reference only, adjustments may be made according to individual needs.
Some common medications Empagliflozin may interact with:
Please notify your doctor or pharmacist if you are taking the above medication, dosage adjustments might be needed.
In Hong Kong, Empagliflozin is a prescription only medicine, and requires a prescription from a doctor to be purchased in a pharmacy. It can also be obtained from doctors. To find a pharmacy near you, refer to the list of pharmacies (“Authorized Sellers of Poisons”) from the Hong Kong Department of Health.
For more information about drug names and ingredients, you can visit Hong Kong’s Drug Office at https://www.drugoffice.gov.hk
Need more information?
For detailed information about the use of Empagliflozin in children, pregnancy and breastfeeding, and for questions about drug interactions, please check with your pharmacist or doctor.
Disclaimer: our goal is to provide you with the most relevant drug information and common dosage for Hong Kong. This information does not constitute medical advice. For specific treatment recommendations and advice, always discuss with your doctor or pharmacist, and follow the instructions included with your specific medicine.